SCHEMBL1477543

SCHEMBL1477543

C=COB(OCCCC)OCCCC

nearest known ligand 0.38

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.38
HPGD P15428 1/20 0.38
ALDH1A1 P00352 1/20 0.33
ADRB2 P07550 1/20 0.33
ADRB1 P08588 1/20 0.33
ADRB3 P13945 1/20 0.33
ATM Q13315 1/20 0.31
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28477417 0.86
SCHEMBL18065841 0.78 TSHR (0.35) TSHRHPGDALDH1A1ADRB2ADRB1
SCHEMBL20224725 0.77 ADRB2 (0.45) TSHRHPGDALDH1A1ADRB2ADRB1
SCHEMBL50476 0.77 ADRB2 (0.45) TSHRHPGDALDH1A1ADRB2ADRB1
SCHEMBL8727179 0.77 ADRB2 (0.45) TSHRHPGDALDH1A1ADRB2ADRB1
SCHEMBL245354 0.77 ADRB2 (0.45) TSHRHPGDALDH1A1ADRB2ADRB1
SCHEMBL9862028 0.75
SCHEMBL8727171 0.75 ADRB2 (0.43) TSHRHPGDALDH1A1ADRB2ADRB1
SCHEMBL11586592 0.75 ADRB2 (0.43) TSHRHPGDALDH1A1ADRB2ADRB1
Ammonia Solution, Strong SCHEMBL28517868 0.75 ADRB2 (0.43) TSHRHPGDALDH1A1ADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119725589-A Lithium carbon fluoride battery 惠州亿纬锂能股份有限公司 2025-03-28 CN claimed
CN-119092666-A Silicon-carbon negative electrode material for lithium ion battery and preparation method thereof 天能新能源(湖州)有限公司 2024-12-06 CN claimed
CN-118648152-A Sodium ion battery electrolyte, sodium ion battery containing same and electricity utilization device 宁德时代新能源科技股份有限公司 2024-09-13 CN claimed
CN-118344633-A Preparation method of copper-free composite resin brake pad 浙江万赛汽车零部件股份有限公司 2024-07-16 CN claimed
CN-118173883-A Electrolyte for improving high-temperature performance of lithium iron phosphate battery and application 中国科学院大连化学物理研究所 2024-06-11 CN claimed
CN-117417387-A Synthesis method of nucleoside analogue 苏州翔实医药发展有限公司 2024-01-19 CN claimed
WO-2024011355-A1 ELECTROLYTE FOR SODIUM-ION BATTERY, SODIUM-ION BATTERY COMPRISING SAME, AND ELECTRIC DEVICE 宁德时代新能源科技股份有限公司 2024-01-18 WO claimed
CN-112341558-B Polymer microsphere, preparation method thereof and lubricating grease composition 深圳市优宝新材料科技有限公司 2023-01-24 CN claimed
CN-112928387-B Boron-containing modified diaphragm, preparation method and application thereof, and battery containing diaphragm 厦门大学 2022-05-03 CN claimed
CN-112928387-A Boron-containing modified diaphragm, preparation method and application thereof, and battery containing diaphragm 厦门大学 2021-06-08 CN claimed
CN-121554862-A Anti-sticking polypropylene material and preparation method thereof 苏州润佳工程塑料股份有限公司 2026-02-24 CN disclosed
CN-121406047-A High heat-resistant polypropylene and preparation method thereof 苏州润佳工程塑料股份有限公司 2026-01-27 CN disclosed
CN-118344633-B Preparation method of copper-free composite resin brake pad 浙江万赛汽车零部件股份有限公司 2025-09-05 CN disclosed
CN-120554727-A Fireproof flame-retardant rubber and preparation method thereof 深圳市捷朗硕电子工业有限公司 2025-08-29 CN disclosed
CN-119725589-A Lithium carbon fluoride battery 惠州亿纬锂能股份有限公司 2025-03-28 CN disclosed
WO-2006035640-A1 LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2006-04-06 WO disclosed
EP-1549613-A1 SULFONAMIDES HAVING ANTIANGIOGENIC AND ANTICANCER ACTIVITY Abbott Laboratories (US) 2005-07-06 EP disclosed
US-20040167128-A1 Sulfonamides having antiangiogenic and anticancer activity ABBVIE INC. 2004-08-26 US disclosed
US-20040157836-A1 Sulfonamides having antiangiogenic and anticancer activity ABBOTT LABORATORIES 2004-08-12 US disclosed
WO-2004033419-A1 SULFONAMIDES HAVING ANTIANGIOGENIC AND ANTICANCER ACTIVITY ABBOTT LABORATORIES (US) 2004-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167128-A1 Sulfonamides having antiangiogenic and anticancer activity METAP2, METAP1, DNPEP TSHR 4446/4885HPGD 3416/4885ALDH1A1 3463/4885
US-20040157836-A1 Sulfonamides having antiangiogenic and anticancer activity METAP2, METAP1, DNPEP TSHR 4446/4885HPGD 3416/4885ALDH1A1 3463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.